The Experts below are selected from a list of 334809 Experts worldwide ranked by ideXlab platform
Bertha K Madras - One of the best experts on this subject based on the ideXlab platform.
-
office of national Drug Control policy
Annals of the New York Academy of Sciences, 2010Co-Authors: Bertha K MadrasAbstract:This essay describes how a basic scientist was thrust into the epicenter, the political cauldron of our national Drug Control policy, and how the experience altered her professional trajectory and perspective.
Damon Barrett - One of the best experts on this subject based on the ideXlab platform.
-
The Case for International Guidelines on Human Rights and Drug Control
Health and human rights, 2017Co-Authors: Rick Lines, Rebecca Schleifer, Richard Elliott, Julie Hannah, Tenu Avafia, Damon BarrettAbstract:Multilateral treaties on Drug Control predate the foundation of international human rights law by several decades. Over the last half-century, these two legal systems have exerted significant influence on state practice. Today, the impact of human rights norms can be seen in policy areas as disparate as warfare, terrorism, trade, intellectual property, the environment, and global health, while the three UN Drug conventions influence domestic Drug Control policy and law in almost every country of the world. However, the two systems are in a position of tension. The human rights impacts of Drug Control are vast, spanning all regions of the world, engaging the full spectrum of civil, political, economic, social, and cultural rights, and affecting the health and welfare of people and communities, whether they have any involvement in the Drug trade or not. International Drug Control law, meanwhile, has evolved largely absent any normative guidance that may be offered by human rights law. This commentary sets out a case for 'international guidelines on human rights and Drug Control', a project being spearheaded by the International Centre on Human Rights and Drug Policy and the UN Development Program in collaboration with the Canadian HIV/AIDS Legal Network and other NGO partners.
-
Security, development and human rights: normative, legal and policy challenges for the international Drug Control system.
The International journal on drug policy, 2010Co-Authors: Damon BarrettAbstract:This commentary addresses some of the challenges posed by the broader normative, legal and policy framework of the United Nations for the international Drug Control system. The ‘purposes and principles’ of the United Nations are presented and set against the threat based rhetoric of the Drug Control system and the negative consequences of that system. Some of the challenges posed by human rights law and norms to the international Drug Control system are also described, and the need for an impact assessment of the current system alongside alternative policy options is highlighted as a necessary consequence of these analyses.
Letizia Paoli - One of the best experts on this subject based on the ideXlab platform.
-
change is possible the history of the international Drug Control regime and implications for future policymaking
Substance Use & Misuse, 2012Co-Authors: Letizia Paoli, Victoria A Greenfield, Peter ReuterAbstract:The article, based upon an extensive literature review, reconstructs and analyzes the parallel evolution of the international Drug Control regime and the world opiate market, assessing the impact of the former on the latter until the rise of present-day mass markets. It shows that, since its inception, the regime has focused almost entirely on matters of supply. However, that focus has not always meant “prohibition”; until 1961, the key principle of the regime was “regulation.” Given the different forms Drug Control policy has taken in the past, the authors conclude it may be amenable to new forms in the future.
-
if supply oriented Drug policy is broken can harm reduction help fix it melding disciplines and methods to advance international Drug Control policy
International Journal of Drug Policy, 2012Co-Authors: Victoria A Greenfield, Letizia PaoliAbstract:Critics of the international Drug Control regime contend that supply-oriented policy interventions are not just ineffective, but they also produce unintended adverse consequences. Research suggests their claims have merit. Lasting local reductions in opium production are possible, albeit rare; but, unless global demand shrinks, production will shift elsewhere, with little or no effect on the aggregate supply of heroin and, potentially, at some expense to exiting and newly emerging suppliers. The net consequences of the international Drug Control regime and related national policies are as yet unknown. In this paper, we consider whether “harm reduction,” a subject of intense debate in the demand-oriented Drug policy community, can provide a unifying foundation for supply-oriented Drug policy, one capable of speaking more directly to policy goals. Despite substantial conceptual and technical challenges, we find that harm reduction can provide a basis for assessing the net consequences of supply-oriented Drug policy, choosing more rigorously among policy options, and identifying new policy options. In addition, we outline a practical path forward for assessing harms and policy options.
Rebecca Schleifer - One of the best experts on this subject based on the ideXlab platform.
-
International Guidelines on Human Rights and Drug Control: A Tool for Securing Women's Rights in Drug Control Policy.
Health and human rights, 2017Co-Authors: Rebecca Schleifer, Luciana PolAbstract:Discrimination and inequality shape women's experiences of Drug use and in the Drug trade and the impact of Drug Control efforts on them, with disproportionate burdens faced by poor and otherwise marginalized women. In recent years, UN member states and UN Drug Control and human rights entities have recognized this issue and made commitments to integrate a 'gender perspective' into Drug Control policies, with 'gender' limited to those conventionally deemed women. But the concept of gender in international law is broader, rooted in socially constructed and culturally determined norms and expectations around gender roles, sex, and sexuality. Also, Drug Control policies often fail to meaningfully address the specific needs and circumstances of women (inclusively defined), leaving them at risk of recurrent violations of their rights in the context of Drugs. This article explores what it means to 'mainstream' this narrower version of gender into Drug Control efforts, using as examples various women's experiences as people who use Drugs, in the Drug trade, and in the criminal justice system. It points to international guidelines on human rights and Drug Control as an important tool to ensure attention to women's rights in Drug Control policy design and implementation.
-
The Case for International Guidelines on Human Rights and Drug Control
Health and human rights, 2017Co-Authors: Rick Lines, Rebecca Schleifer, Richard Elliott, Julie Hannah, Tenu Avafia, Damon BarrettAbstract:Multilateral treaties on Drug Control predate the foundation of international human rights law by several decades. Over the last half-century, these two legal systems have exerted significant influence on state practice. Today, the impact of human rights norms can be seen in policy areas as disparate as warfare, terrorism, trade, intellectual property, the environment, and global health, while the three UN Drug conventions influence domestic Drug Control policy and law in almost every country of the world. However, the two systems are in a position of tension. The human rights impacts of Drug Control are vast, spanning all regions of the world, engaging the full spectrum of civil, political, economic, social, and cultural rights, and affecting the health and welfare of people and communities, whether they have any involvement in the Drug trade or not. International Drug Control law, meanwhile, has evolved largely absent any normative guidance that may be offered by human rights law. This commentary sets out a case for 'international guidelines on human rights and Drug Control', a project being spearheaded by the International Centre on Human Rights and Drug Policy and the UN Development Program in collaboration with the Canadian HIV/AIDS Legal Network and other NGO partners.
Jody P. Garthwaite - One of the best experts on this subject based on the ideXlab platform.
-
Reform of Drug Control policy for palliative care in Romania.
Lancet (London England), 2006Co-Authors: Daniela Mosoiu, Karen M. Ryan, David E. Joranson, Jody P. GarthwaiteAbstract:Summary Unrelieved pain from cancer and HIV/AIDS is a substantial worldwide public-health problem. Inadequate pain relief is partly due to excessively strict national Drug-Control policies that constrain medical use of essential medicines such as morphine. Romania's Drug-Control policies are more than 35 years old and impose an antiquated regulatory system that is based on inpatient post-surgical management of acute pain that restricts prescription authority and makes access to opioid treatment difficult for outpatients with severe chronic pain due to cancer or HIV/AIDS. A Ministry of Health palliative-care commission used WHO guidelines to assess and recommend changes to Romania's national Drug Control law and regulations. The Romanian parliament has adopted a new law that will simplify prescribing requirements and allow modern pain management. Achievement of adequate pain relief is a vital part of worldwide health and will be dependent on reform of antiDrug regulations in many countries.
-
Reform of Drug Control policy for palliative care in Romania. Commentary
The Lancet, 2006Co-Authors: Julia Riley, Daniela Mosoiu, Karen M. Ryan, David E. Joranson, Joy R. Ross, Jody P. GarthwaiteAbstract:Unrelieved pain from cancer and HIV/AIDS is a substantial worldwide public-health problem. Inadequate pain relief is partly due to excessively strict national Drug-Control policies that constrain medical use of essential medicines such as morphine. Romania's Drug-Control policies are more than 35 years old and impose an antiquated regulatory system that is based on inpatient post-surgical management of acute pain that restricts prescription authority and makes access to opioid treatment difficult for outpatients with severe chronic pain due to cancer or HIV/AIDS. A Ministry of Health palliative-care commission used WHO guidelines to assess and recommend changes to Romania's national Drug Control law and regulations. The Romanian parliament has adopted a new law that will simplify prescribing requirements and allow modern pain management. Achievement of adequate pain relief is a vital part of worldwide health and will be dependent on reform of antiDrug regulations in many countries.
